We have attached press release for Financial Results for the Quarter Ended June 30, 2026.
Kindly take the same on your record.
Thank you.
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 31 Jul 2026, 10:47 AM IST · BSE ID: 54d02ee7-c303-4e87-aba5-2421fbef769b
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's quarterly income and profit grew significantly, driven by a strategic acquisition into new product segments.
🤖 AI Summary
- Consolidated Total Income for Q1FY27 increased by 163.02% YoY to ₹87.62 Crore.
- Consolidated EBITDA grew by 150.14% to ₹15.65 Crore, and PAT by 133.13% to ₹8.28 Crore.
- Acquired 63.98% stake in Remember India Health Links Pvt. Ltd. for ₹5.38 Crore on May 8, 2026.
- Expanded into Finished Dosage Formulations (FDF) segment, gaining access to 30+ formulation dossiers.
- Broadened market presence in B2B APIs, domestic retail, and hospital markets during the quarter.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Total Income
₹87.62 Crore
163.02%
EBITDA
₹15.65 Crore
150.14%
Acquisition Cost
₹5.38 Crore
🏢 How This Affects the Company
The acquisition of Remember India Health Links Pvt. Ltd. expands Anlon Healthcare's market presence into Finished Dosage Formulations (FDF) and broadens its product portfolio with over 30 formulation dossiers, complementing its existing API business.
The company reported substantial year-on-year growth in consolidated Total Income (163.02%), EBITDA (150.14%), and PAT (133.13%) for Q1FY27, reflecting improved operational efficiencies and contributions from strategic acquisitions.
The integration of Remember India Health Links Pvt. Ltd. enhances manufacturing capabilities, strengthens quality control processes, and creates operational synergies across the pharmaceutical value chain.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected as these consolidated financial results reflect the company's overall operational and financial performance for Q1FY27.
🔍
Management Signal
Management is focused on expanding the company's pharmaceutical value chain through strategic acquisitions and operational integration.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 financial results — check for sustained growth.
Updates on FDF segment integration and new product launches.
Progress on expansion into regulated markets as stated by management.
LOW RISK
Filing reports strong financial growth and strategic expansion, with no immediate risks indicated.
💡 Investor Takeaway
Anlon Healthcare's consolidated Total Income for Q1FY27 rose 163.02% YoY to ₹87.62 Crore, with PAT increasing 133.13% to ₹8.28 Crore. This performance includes contributions from the acquisition of a 63.98% stake in Remember India Health Links Pvt. Ltd. for ₹5.38 Crore.
⚖️ Strengths & Concerns
✅ Positives
- Consolidated Total Income increased by 163.02% year-on-year to ₹87.62 Crore in Q1FY27.
- Consolidated Profit After Tax (PAT) grew by 133.13% to ₹8.28 Crore for Q1FY27.
📅 Company Track Record
Anlon Healthcare's Q1 FY27 consolidated profit of ₹8.28 Crore shows significant growth compared to the standalone profit of ₹479.71 Lakhs reported for Q1 FY27 in the July 30, 2026, filing, indicating the impact of consolidation and recent strategic acquisitions. The company was incorporated in 2013.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Anlon Healthcare's consolidated Total Income for Q1 FY27?
Anlon Healthcare reported a consolidated Total Income of ₹87.62 Crore for the quarter ended June 30, 2026, marking a 163.02% year-on-year increase.
What was Anlon Healthcare's consolidated Profit After Tax (PAT) for Q1 FY27?
The consolidated Profit After Tax (PAT) for Anlon Healthcare in Q1 FY27 was ₹8.28 Crore, reflecting a 133.13% year-on-year growth.
What was the EBITDA for Anlon Healthcare in Q1 FY27?
Anlon Healthcare's consolidated EBITDA for Q1 FY27 was ₹15.65 Crore, which is a 150.14% increase compared to Q1 FY26.
Which company did Anlon Healthcare acquire during Q1 FY27?
Anlon Healthcare acquired a 63.98% stake in Remember India Health Links Pvt. Ltd. for a consideration of ₹5.38 Crore, with the transaction completed on May 8, 2026.
How has Anlon Healthcare expanded its business operations?
Anlon Healthcare expanded into the Finished Dosage Formulations (FDF) segment through the acquisition of Remember India Health Links Pvt. Ltd., gaining access to 30+ formulation dossiers and broadening its market presence.
Questions based on this BSE filing only. For information purposes.